Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Enhancing Gait Using Alternating-Frequency DBS in Parkinson Disease

NCT: NCT05022147 · ACTIVE_NOT_RECRUITING

NCT IDNCT05022147
StatusACTIVE_NOT_RECRUITING
Start Date2021-10-04
Completion2026-12
SponsorJames Liao (OTHER)
First posted
Last updated

Brief Summary

The purpose of this study is to assess how alternating-frequency Deep Brain Stimulation (DBS) works to improve postural instability and gait, while also treating other motor symptoms of Parkinson Disease (PD).

Frequently Asked Questions

What is Enhancing Gait Using Alternating-Frequency DBS in Parkinson Disease?

Enhancing Gait Using Alternating-Frequency DBS in Parkinson Disease is a clinical trial registered under NCT05022147. Current status: ACTIVE_NOT_RECRUITING.

What is the status of NCT05022147?

The current status of NCT05022147 (Enhancing Gait Using Alternating-Frequency DBS in Parkinson Disease) is: ACTIVE_NOT_RECRUITING.

When did Enhancing Gait Using Alternating-Frequency DBS in Parkinson Disease start?

Enhancing Gait Using Alternating-Frequency DBS in Parkinson Disease started on 2021-10-04.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.